Literature DB >> 20010720

New vaccine development for chronic brain disease.

Alan Dt Barrett1, Rakez Kayed, George R Jackson, Kathryn A Cunningham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20010720      PMCID: PMC3055416          DOI: 10.1038/npp.2009.147

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  5 in total

Review 1.  New horizons in adjuvants for vaccine development.

Authors:  Steven G Reed; Sylvie Bertholet; Rhea N Coler; Martin Friede
Journal:  Trends Immunol       Date:  2008-12-06       Impact factor: 16.687

2.  Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses.

Authors:  Bryce Chackerian; Marisa Rangel; Zoe Hunter; David S Peabody
Journal:  Vaccine       Date:  2006-06-06       Impact factor: 3.641

3.  Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.

Authors:  Gregory D Gromowski; Alan D T Barrett
Journal:  Virology       Date:  2007-08-23       Impact factor: 3.616

Review 4.  Substance abuse vaccines.

Authors:  Frank M Orson; Berma M Kinsey; Rana A K Singh; Yan Wu; Tracie Gardner; Thomas R Kosten
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 5.  Prefilament tau species as potential targets for immunotherapy for Alzheimer disease and related disorders.

Authors:  Rakez Kayed; George R Jackson
Journal:  Curr Opin Immunol       Date:  2009-05-30       Impact factor: 7.486

  5 in total
  2 in total

1.  Heat shock factor 1 over-expression protects against exposure of hydrophobic residues on mutant SOD1 and early mortality in a mouse model of amyotrophic lateral sclerosis.

Authors:  Pei-Yi Lin; Sharotka M Simon; Won Kyun Koh; Oluwarotimi Folorunso; C Samuel Umbaugh; Anson Pierce
Journal:  Mol Neurodegener       Date:  2013-11-21       Impact factor: 14.195

2.  Ethical issues in early diagnosis and prevention of Alzheimer disease.

Authors:  Peter J Whitehouse
Journal:  Dialogues Clin Neurosci       Date:  2019-03       Impact factor: 5.986

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.